Sep01Thu
Aug09Tue
From Irish Echo
By Ray O’Hanlon
rohanlon@irishecho.com
Many Americans are in Ireland this month enjoying often long-planned vacations in their ancestral homeland.
Some of them are hankering to stay.
And those Americans wanting to retire to Ireland are urging changes in current financial requirements that make it impossible for many of them to meet the Irish government’s annual income rules.
Two petitions are now seeking signatures in support of the effort to lower the financial bar for residency. In response to the calls from this side of the Atlantic, and questions being asked in the Dail, mainly by Fine Gael TD Fergus O’Dowd, the Irish government has undertaken a review of the requirements starting with a “consultation phase.”
Details of the review are being made available on the website of the Irish Naturalization and Immigration Service (INIS) and “interested parties” are being asked to submit views to a dedicated email address.
Aug08Mon
|
|
|
| Craigavon, N.I., UK, – Monday 08 August 2016 Almac Group’s Diagnostics business unit today announced the publication of the second validation study of their stage II colon cancer recurrence signature ColDx in the Journal of Clinical Oncology (JCO).The publication entitled ‘Association Between Results of a Gene Expression Signature Assay and Recurrence-Free Interval in Patients With Stage II Colon Cancer in Cancer and Leukemia Group B 9581 (Alliance)’ demonstrates that the ColDx assay is a significant, independent predictor of recurrence-free interval (RFI) in stage II colon cancer therefore indicating it’s potential utility with the traditional clinical markers of risk to refine patient prognosis.
The study was performed in conjunction with the Alliance for Clinical Trials in Oncology (Alliance) comprised of investigators from renowned institutions such as Duke University, Dana-Farber Cancer Institute, University of Chicago, Brigham and Women’s Hospital and Queen’s University Belfast. |
IABCN Board Members with Ambassador Anne Anderson, Consul General Barbara Jones, Tánaiste Frances Fitzgerald and Chairman of the Board of The Rosenbach Museum & Library, Arthur Spector.
(front row, left to right) Ambassador Anderson, Consul General Barbara Jones, Christine Hartmann, Tánaiste Fitzgerald and Kevin Kent
(front row) Arthur Spector and Siobhan Reardon
(back row) Sean Flatley and Bill McLaughlin
Click below to view more photos from our welcoming reception at The Rosenbach on July 25, 2016.
ICON has announced financial results for the second quarter 2016. Please find details below. Full consolidated income statements and summary balance sheet data can be read here.
Some highlights from the quarter include:
• ICON’s acquisition of ClinicalRM which has extended ICON’s presence in the market for government-funded research and has enhanced ICON’s capabilities in vaccines and infectious disease. At the height of the Ebola crisis, ClinicalRM worked on several clinical trials in West Africa and the company is currently supporting the Zika Emergency Response plan.
• A renewal of ICON’s service agreement with Pfizer, where ICON will continue to provide expertise in the planning, execution and management of Pfizer’s clinical trials. ICON first entered into a strategic partnership with Pfizer in 2011.
